Category Archives: Recent News

BriaCell Therapeutics Corp. Announces Share Consolidation

BERKELEY, Calif., and VANCOUVER, British Columbia, December 24, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell to Present at Biotech Showcase™ 2020 in San Francisco

BERKELEY, Calif., and VANCOUVER, British Columbia, December 17, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Clinical Data as Presented at the 2019 San Antonio Breast Cancer Symposium®

Safety and early efficacy data were presented on December 12th at 6:00 p.m. ET from ...

BriaCell to Present Clinical Findings at the 2019 San Antonio Breast Cancer Symposium® December 12th and 13th

Safety and early efficacy data to be presented from clinical trial of Bria-IMT™ in combination ...

BriaCell Announces Voting Results of the Special Meeting of Shareholders

BERKELEY, Calif., and VANCOUVER, British Columbia, October 24, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Closing of Non-Brokered Private Placement of $568,444

BERKELEY, Calif., and VANCOUVER, British Columbia, October 15, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Therapeutics Corp. to File Amendment to Management Information Circular

BERKELEY, Calif., and VANCOUVER, British Columbia, October 8, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Doses First Patient in Phase I/IIa Study Evaluating Bria-IMT™ in Combination with INCMGA00012 and Epacadostat in Patients with Advanced Breast Cancer

• Patient dosing has begun in the Phase I/IIa study evaluating the anti-tumor effects of ...

BriaCell Therapeutics Corp. to Clarify Record Date

BERKELEY, Calif., and VANCOUVER, British Columbia, October 1, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

Note from Chairman of BriaCell Therapeutics – October is Breast Cancer Awareness Month

BERKELEY, Calif., and VANCOUVER, British Columbia, October 1, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...